Dow Up0.25% Nasdaq Up0.65%

More On 1093.HK

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


CSPC PHARMA (1093.HK)

-HKSE
6.93 Up 0.13(1.91%) May 27, 3:59AM EDT
ProfileGet Profile for:
CSPC PHARMA
No.226 Huanghe Street
Shijiazhuang, 050035
China - Map
Phone: 86 311 8703 7015
Fax: 86 311 8703 9608
Website: http://www.cspc.com.hk

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:10,023

Business Summary 

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It operates through Finished Drugs, Antibiotics, Vitamin C, and Caffeine and Others segments. It offers finished drugs, including NBP series used for the treatment of acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning series principally for the treatment of hypertension and angina pectoris; Duomeisu, a chemotherapy drug for the treatment of lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; and Nuolining, a small molecule targeted cancer drug. The company also provides generic drugs, such as Qingre Jiedu, Ganmao Qingre, Yin Huang, Xiangsha Yangwei, and Huoxiang Qushu soft capsules, as well as Zhongnuo Shuluoke injection and health supplement products; antibiotics, vitamin C products, and caffeine and other drugs; and traditional Chinese medicines. In addition, it has 170 products under research and development with focus on the therapeutic areas of cardio-cerebrovascular, diabetes, oncology, neurology, and anti-infection. Further, the company provides pharmaceutical research and development services, as well as sewage and pharmaceutical by-products; and trades in pharmaceutical products. It has operations in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is headquartered in Shijiazhuang, the People’s Republic of China.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on CSPC PHARMA

Key Executives 
 PayExercised
Mr. Dongchen Cai , 62
Exec. Chairman, Chief Exec. Officer, Managing Director and Chairman of Nomination Committee
11.33MN/A
Mr. Weidong Pan , 46
Chief Accountant, Exec. Director and Director of Shijiazhuang Pharmaceutical Group Company Limite
2.69MN/A
Mr. Kin Man Chak , 50
Exec. Director
4.79MN/A
Dr. Shunlong Wang Ph.D., 52
Exec. Director
0.00N/A
Mr. Huaiyu Wang , 53
Exec. Director
2.68MN/A
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in HKD.